The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest plasma therapy market share, and Middle East was the fastest-growing region in 2022.

The global plasma therapy market is expected to grow from $0.4 billion in 2022 to $0.44 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The plasma therapy market is expected to grow from $0.69 billion in 2027 at a CAGR of 11.7%.

Major Driver In The Plasma Therapy Market ­– Rise In The Prevalence Of Osteoarthritis
According to the Centres for Disease Control and Prevention (CDC), around 32.5 million persons in the United States would have osteoarthritis in July 2020. Autologous chondrocyte implantation and scaffold implants are two of the most regularly used therapies for osteoarthritis. As a result, an increase in the prevalence of osteoarthritis will boost the plasma therapy market.

View More On The Plasma Therapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Key Plasma Therapy Market Segments
1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopaedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Recent Plasma Therapy Market Trend – Adopting Convalescent Plasma Therapy
Convalescent plasma treatment, used to treat COVID-19 patients, is a major trend in the plasma therapy industry. Convalescent plasma is plasma taken from people who have been cured of a specific viral infection because they have antibodies that protect them and make them resistant to that organism. Convalescent plasma is administered to a patient suffering from a viral infection in order to neutralise the infection and stimulate an aggressive immune response in order to treat the infection. Convalescent plasma therapy has been demonstrated to be a safe treatment for coronavirus infection. Furthermore, this medication was tried to treat other viral illnesses such as Ebola, Dengue, and SARS-1, but it did not work. Takeda Pharmaceutical Company Limited launched TAK-888, an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) plasma therapy, in March 2020 to treat COVID-19. The TAK-888 uses plasma taken from convalescent donors who have been cured of COVID-19 and is delivered to the COVID-19 patient.

Plasma Therapy Market Prominent Players
Major players in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex, Inc., Biotest AG, China Biologic Products Holdings, Inc., DePuy Synthes Companies, CSL Limited, Grifols, S.A., Octapharma, and Terumo BCT Inc.

Request A Sample Of The Global Plasma Therapy Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

The Plasma Therapy Global Market Report 2023  provides a comprehensive overview on the plasma therapy market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Plasma therapy is a treatment that replaces missing or insufficient proteins to help individuals live healthier and more productive lives. Using blood provided by recovered patients, it transfers antibodies into individuals receiving therapy.

View More Related Reports –
Convalescent Plasma Therapy Global Market Report 2023
Plasma Fractionation Global Market Report 2023
Plasma Protein Therapeutics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model